lysine has been researched along with lutetium lu 177 dotatate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bernard, B; Bijster, M; de Jong, M; Forrer, F; Krenning, EP; Rolleman, EJ; Valkema, R; Vermeij, M | 1 |
Bernard, BF; Boerman, OC; Breeman, WA; de Blois, E; de Jong, M; Forrer, F; Gotthardt, M; Hoppin, J; Krenning, EP; Rolleman, EJ | 1 |
Berndsen, SC; Boerman, OC; de Jong, M; de Swart, J; de Visser, M; Koelewijn, S; Krenning, EP; Melis, M; Valkema, R | 1 |
Al-Toubah, T; Bottiglieri, S; El-Haddad, G; Hutchinson, T; Jesurajan, J; Pellé, E; Sikaria, D; Smith, J; Strosberg, J | 1 |
4 other study(ies) available for lysine and lutetium lu 177 dotatate
Article | Year |
---|---|
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Topics: Amifostine; Animals; Body Weight; Creatinine; Kidney; Lysine; Male; Neoplasms; Octreotide; Organometallic Compounds; Proteinuria; Radiation Injuries; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Tomography, Emission-Computed, Single-Photon | 2007 |
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.
Topics: Animals; Biological Transport; Drug Hypersensitivity; Humans; Kidney; Lutetium; Lysine; Octreotide; Organometallic Compounds; Polygeline; Radioisotopes; Rats; Tomography, Emission-Computed, Single-Photon | 2008 |
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Topics: Albumins; Animals; Autoradiography; Creatinine; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Tubules; Lysine; Male; Octreotide; Organometallic Compounds; Pentetic Acid; Proteinuria; Radiation Injuries; Radioisotope Renography; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Mertiatide; Tomography, Emission-Computed, Single-Photon | 2010 |
Comparison of Nausea and Vomiting Associated With Amino Acid Formulations Coinfused With Peptide Receptor Radionuclide Therapy: Commercial Parenteral Nutrition Formulas Versus Compounded Arginine/Lysine.
Topics: Aged; Aged, 80 and over; Amino Acids; Arginine; Combined Modality Therapy; Female; Humans; Infusion Pumps; Lysine; Male; Middle Aged; Nausea; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Outcome Assessment, Health Care; Parenteral Nutrition; Radiopharmaceuticals; Receptors, Peptide; Retrospective Studies; Vomiting | 2021 |